State Street Corp Enochian Biosciences Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Enochian Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 1,323,832 shares of ENOB stock, worth $6.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,323,832

Previous 1,275,718 3.77%

Holding current value

$6.09 Million

Previous $5.87 Million 3.77%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	N/A	48,114 Added 3.77%	1,323,832 $6.09 Million
Q2 2024 Aug 14, 2024	BUY	N/A	1,178,031 Added 1205.92%	1,275,718 $5.87 Million
Q4 2023 Feb 14, 2024	BUY	$4.3 - $4.7 $147,490 - $161,210	34,300 Added 54.11%	97,687 $449,000
Q3 2023 Nov 14, 2023	BUY	$0.0 - $4.46 $0 - $50,398	11,300 Added 21.69%	63,387 $282,000
Q2 2023 Aug 14, 2023	SELL	$0.4 - $1.3 $102,128 - $331,917	-255,321 Reduced 83.06%	52,087 $29,000
Q1 2023 May 15, 2023	BUY	$0.91 - $1.31 $1,638 - $2,358	1,800 Added 0.59%	307,408 $282,000
Q4 2022 Feb 14, 2023	SELL	$1.03 - $2.13 $11,037 - $22,825	-10,716 Reduced 3.39%	305,608 $314,000
Q3 2022 Nov 15, 2022	SELL	$1.7 - $2.86 $246 - $414	-145 Reduced 0.05%	316,324 $573,000
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $510,257 - $2.31 Million	264,382 Added 507.58%	316,469 $611,000
Q1 2022 May 16, 2022	BUY	$4.42 - $9.0 $16,778 - $34,164	3,796 Added 7.86%	52,087 $430,000
Q3 2021 Nov 15, 2021	BUY	$4.56 - $7.88 $70,680 - $122,140	15,500 Added 47.27%	48,291 $325,000
Q2 2021 Aug 16, 2021	SELL	$2.94 - $6.79 $456,820 - $1.06 Million	-155,381 Reduced 82.57%	32,791 $163,000
Q1 2021 May 17, 2021	BUY	$3.02 - $4.51 $906 - $1,353	300 Added 0.16%	188,172 $666,000
Q4 2020 Feb 16, 2021	SELL	$2.82 - $3.55 $13,254 - $16,685	-4,700 Reduced 2.44%	187,872 $554,000
Q3 2020 Nov 10, 2020	BUY	$3.42 - $4.55 $130,148 - $173,150	38,055 Added 24.63%	192,572 $689,000
Q2 2020 Aug 14, 2020	BUY	$2.78 - $6.06 $88,265 - $192,405	31,750 Added 25.86%	154,517 $651,000
Q1 2020 May 11, 2020	BUY	$2.08 - $5.41 $255,355 - $664,169	122,767 New	122,767 $368,000

Others Institutions Holding ENOB

# of Institutions

Shares Held

14.7M

Call Options Held

24K

Put Options Held

19.1K

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Enochian Biosciences Inc Transaction History